Impact and effect mechanisms of mass campaigns in resource-constrained health systems: quasi-experimental evidence from polio eradication in Nigeria.
health systems
immunisation
poliomyelitis
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
19
10
2020
revised:
12
01
2021
accepted:
10
02
2021
entrez:
9
3
2021
pubmed:
10
3
2021
medline:
25
6
2021
Statut:
ppublish
Résumé
Mass campaigns are a key strategy for delivering life-saving interventions under Global Health Initiatives, especially in weak health system contexts. They are frequently designed parallel to the health system to rapidly achieve programme targets such as vaccination coverage, but we lack quantitative evidence demonstrating their impact and effect mechanisms on health system performance at sub-/national level. This longitudinal study responds to this gap through an analysis of polio eradication campaigns in Nigeria. Using four rounds of Demographic and Health Surveys in Nigeria between October 2000 and December 2017, we created a longitudinal dataset containing 88 881 under-5 children/pregnancies. We estimated the relationships between individuals' campaign exposure and health system performance indices (full RI schedule attainment, maternal healthcare services utilisation and child survival) using multilevel, mixed-effects regression models applied nationally and stratified by the six geopolitical zones in Nigeria. Nationally, high-frequency mass campaigns had detrimental health systems effects that potentially left 3.6 million children deprived of full immunisation. The frequency of campaigns was most concentrated in regions with weak health systems, where the operations of RI were disrupted, alongside negative effects on child survival and institutional delivery. In contrast, regions with relatively strong health systems and few campaigns experienced beneficial effects on maternal healthcare service utilisation. As we provide evidence that well-functioning health systems can benefit from mass campaigns under Global Health Initiatives, our work also challenges the established wisdom to intensify mass campaigns in weaker health systems to bypass service provision bottlenecks. Mass campaigns do not inherently benefit or damage a health system, but frequent campaigns in weak health system contexts can impede service provision. We call for an additional burden of proof and active efforts to integrate mass campaigns into routine health services by harmonising implementation plans and service delivery in weak health system contexts.
Sections du résumé
BACKGROUND
Mass campaigns are a key strategy for delivering life-saving interventions under Global Health Initiatives, especially in weak health system contexts. They are frequently designed parallel to the health system to rapidly achieve programme targets such as vaccination coverage, but we lack quantitative evidence demonstrating their impact and effect mechanisms on health system performance at sub-/national level. This longitudinal study responds to this gap through an analysis of polio eradication campaigns in Nigeria.
METHODS
Using four rounds of Demographic and Health Surveys in Nigeria between October 2000 and December 2017, we created a longitudinal dataset containing 88 881 under-5 children/pregnancies. We estimated the relationships between individuals' campaign exposure and health system performance indices (full RI schedule attainment, maternal healthcare services utilisation and child survival) using multilevel, mixed-effects regression models applied nationally and stratified by the six geopolitical zones in Nigeria.
RESULTS
Nationally, high-frequency mass campaigns had detrimental health systems effects that potentially left 3.6 million children deprived of full immunisation. The frequency of campaigns was most concentrated in regions with weak health systems, where the operations of RI were disrupted, alongside negative effects on child survival and institutional delivery. In contrast, regions with relatively strong health systems and few campaigns experienced beneficial effects on maternal healthcare service utilisation.
CONCLUSIONS
As we provide evidence that well-functioning health systems can benefit from mass campaigns under Global Health Initiatives, our work also challenges the established wisdom to intensify mass campaigns in weaker health systems to bypass service provision bottlenecks. Mass campaigns do not inherently benefit or damage a health system, but frequent campaigns in weak health system contexts can impede service provision. We call for an additional burden of proof and active efforts to integrate mass campaigns into routine health services by harmonising implementation plans and service delivery in weak health system contexts.
Identifiants
pubmed: 33685940
pii: bmjgh-2020-004248
doi: 10.1136/bmjgh-2020-004248
pmc: PMC7942242
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
BMC Public Health. 2020 Jan 29;20(1):123
pubmed: 31996184
PLoS One. 2019 Feb 14;14(2):e0212049
pubmed: 30763389
Lancet Infect Dis. 2015 Oct;15(10):1183-1192
pubmed: 26179316
Vaccine. 2017 Nov 7;35(47):6438-6443
pubmed: 29031691
J Infect Dis. 2016 May 1;213 Suppl 3:S140-6
pubmed: 26908718
BMC Public Health. 2020 Aug 12;20(Suppl 2):1176
pubmed: 32787949
Med Anthropol Q. 2016 Sep;30(3):321-41
pubmed: 26818631
J Infect Dis. 2011 Jul;204 Suppl 1:S82-9
pubmed: 21666218
J Infect Dis. 2014 Nov 1;210 Suppl 1:S531-9
pubmed: 25316877
Vaccine. 2016 Oct 10;34(43):5150-5154
pubmed: 27395564
Health Policy Plan. 2017 Jul 1;32(6):800-808
pubmed: 28335014
Demography. 2003 Aug;40(3):395-418
pubmed: 12962055
Lancet. 2009 Jun 20;373(9681):2137-69
pubmed: 19541040
J Immunol Sci. 2018 Aug 2;Suppl:135-139
pubmed: 30957102
Vaccine. 2016 Jul 19;34(33):3817-22
pubmed: 27269060
PLoS Med. 2013 Oct;10(10):e1001529
pubmed: 24115915
Health Policy Plan. 2016 Nov;31(9):1225-31
pubmed: 27175031
J Infect Dis. 2014 Nov 1;210 Suppl 1:S504-13
pubmed: 24690667
Health Policy. 2004 Dec;70(3):327-45
pubmed: 15488998
BMC Health Serv Res. 2017 Mar 1;17(1):172
pubmed: 28249578
J Infect Dis. 2017 Jul 1;216(suppl_1):S280-S286
pubmed: 28838201
Bull World Health Organ. 2019 Jan 1;97(1):24-32
pubmed: 30618462
J Infect Dis. 1997 Feb;175 Suppl 1:S268-71
pubmed: 9203728
BMJ Glob Health. 2018 May 7;3(3):e000466
pubmed: 29755760
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720932698
pubmed: 32508212
J Infect Dis. 2017 Jul 1;216(suppl_1):S244-S249
pubmed: 28838165
Soc Sci Med. 1995 Sep;41(5):617-32
pubmed: 7502096